Shanghai Easy-Flow Medical Tech Co., Ltd. (“Easy-Flow™”) has recently announced its partnership with Control Medical Technology, LLC (“Control Medical”) to commercialize the Control mechanical thrombectomy platform in China.

Control Medical Technology, LLC is based in Hallandale, Florida, USA. Its platform includes the FDA cleared Control 5 -11F Mechanical Thrombectomy System indicated for peripheral vasculature, the Control RX-LP Mechanical Thrombectomy System indicated for peripheral and coronary vasculature, and the Control Mechanical Aspirator indicated for peripheral or coronary vasculature. The Control thrombectomy system can deliver continuous and pulsed force to achieve more efficient, flexible and controllable aspiration, through innovative manually-operated aspirator. In addition, it's available in different sizes, providing clinicians a full range of options for thrombectomy.

"Targeting, control, and reducing blood-loss is important when removing blood clots," said Lawrence S. Kronick, co-Founder Control Medical Technology. “Control's system includes peripheral and coronary thrombectomy catheters powered by a single-use mechanical aspirator or electric pump for improved precision and force with low-blood-loss. We are excited to partner with Shanghai Easy-Flow™ to commercialize the Control platform in China".

"The introduction of Control's thrombectomy technology to China represents a significant step forward in our strategy to create an comprehensive product portfolio of minimally invasive vascular solutions." said Zhenghua MIAO, Chairman and General Manager of Easy-Flow™. "Blood clots occur in large and small arteries and veins. So, clinicians need a diverse set of tools to a wide variety of conditions. Control Medical addresses thrombectomy needs with peripheral & coronary catheters powered by a best-in-class single-use mechanical aspirator and/or electric pump. We look forward to launching the innovative products in China, which provide precise, efficient, and cost-effective solutions for patients and physicians in China". 

In the future, Easy-Flow™ will strive for continuous innovation, dedicated to creating integrated solutions that address clinical needs, through a dual-wheel drive of independent R&D and external collaboration.